PT  - JOURNAL ARTICLE
AU  - Park, Junsik
AU  - Lee, Jung Bok
AU  - Lim, Myong Cheol
AU  - Kim, Byoung-Gie
AU  - Kim, Jae-Weon
AU  - Kim, Sunghoon
AU  - Choi, Chel Hun
AU  - Kim, Hee Seung
AU  - Park, Sang Yoon
AU  - Lee, Jung-Yun
ED  - ,
TI  - Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
AID  - 10.1136/jitc-2023-007444
DP  - 2023 Oct 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e007444
VI  - 11
IP  - 10
4099  - http://jitc.bmj.com/content/11/10/e007444.short
4100  - http://jitc.bmj.com/content/11/10/e007444.full
SO  - J Immunother Cancer2023 Oct 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.